Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
130
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Trends in DTR, CR, ECR, and FQR in Four Common Gram-Negative Bacteria: A Retrospective Study from 2013 to 2021

Zhen Zhang1 Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People’s Republic of ChinaView further author information
&
Lei Tian2 Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 2625-2631 | Published online: 23 May 2022

References

  • Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial Resistance. JAMA. 2016;316(11):1193–1204. doi:10.1001/jama.2016.11764
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
  • Bassetti M, Vena A, Sepulcri C, Giacobbe DR, Peghin M. Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance. Antibiotics. 2020;9(9):314. doi:10.3390/antibiotics9090632
  • Kadri SS, Adjemian J, Lai YL, et al. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clin Infect Dis. 2018;67(12):1803–1814. doi:10.1093/cid/ciy378
  • Huh K, Chung DR, Ha YE, et al. Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: retrospective Analysis of Nationwide Surveillance Data. Clin Infect Dis. 2020;71(9):e487–e96. doi:10.1093/cid/ciaa084
  • Zhang Z, Sun Z, Tian L. Antimicrobial Resistance Among Pathogens Causing Bloodstream Infections: a Multicenter Surveillance Report Over 20 Years (1998-2017). Infect Drug Resist. 2022;15:249–260. doi:10.2147/IDR.S344875
  • Clinical and Laboratory Standards Institute. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data, M39-A4. Wayne, PA: Clin Lab Stand Institute; 2014.
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, Thirtieth Informational Supplement, M100-S30. Wayne, PA: Clin Lab Stand Institute; 2020.
  • Wang H, Wang H, Yu X, et al. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010-2016: a retrospective observational study. BMJ Open. 2019;9(8):e026072. doi:10.1136/bmjopen-2018-026072
  • Wanla W, Katip W, Supakul S, et al. Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation. Int J Gen Med. 2017;10:443–449. doi:10.2147/IJGM.S145133
  • Li J, Huang Z, Tang M, et al. Clonal Dissemination of Multiple Carbapenemase Genes in Carbapenem-Resistant Enterobacterales Mediated by Multiple Plasmids in China. Infect Drug Resist. 2021;14:3287–3295. doi:10.2147/IDR.S327273
  • Chen HY, Jean SS, Lee YL, et al. Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: a Global and Narrative Review. Front Cell Infect Microbiol. 2021;11:601968. doi:10.3389/fcimb.2021.601968
  • Lin Q, Wang Y, Yu J, et al. Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection. BMC Infect Dis. 2021;21(1):638. doi:10.1186/s12879-021-06315-0
  • Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens. 2021;10(3):2154. doi:10.3390/pathogens10030373
  • Feng W, Huang Q, Wang Y, et al. Changes in the resistance and epidemiological characteristics of Pseudomonas aeruginosa during a ten-year period. J Microbiol Immunol Infect. 2021;54(2):261–266. doi:10.1016/j.jmii.2019.08.017
  • Katip W, Uitrakul S, Oberdorfer P. Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients. Pharmaceutics. 2021;14(1):365. doi:10.3390/pharmaceutics14010031
  • Katip W, Uitrakul S, Oberdorfer P. A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: a Propensity Score-Matched Analysis. Antibiotics. 2020;9(10):871. doi:10.3390/antibiotics9100647
  • Katip W, Oberdorfer P. Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: a Propensity Score-Matched Analysis. Pharmaceutics. 2021;13(2):87. doi:10.3390/pharmaceutics13020162

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.